Working Up Relapsing Optic Neuritis: A Patient with Undiagnosed Chronic Relapsing Optic Neuritis
DOI:
https://doi.org/10.48560/rspo.40293Keywords:
Neuromyelitis Optica/diagnosis, Optic Neuritis/diagnosis, Tomography, Optical CoherenceAbstract
Chronic relapsing inflammatory optic neuropathy (CRION) presents itself as a challenging clinical diagnosis, due to its rarity, mimicking clinical entities and workup required to obtain a well-substantiated diagnosis, deliver adequate treatment, and exclude potentially life-threatening differential diagnoses. A male patient presented with various episodes of optic neuritis. A full work-up was performed, including magnetic resonance imaging, lumbar puncture, and serologies for infectious and autoimmune diseases. Temporarily elevated levels of angiotensin-converting enzyme hampered the correct diagnosis, as repeat blood work was normal. After excluding multiple sclerosis, neuromyelitis optica, infectious and other autoimmune etiologies, the most likely diagnosis remained CRION. CRION should be kept as a differential diagnosis early during the disease course and repeat exams should be done whenever they do not match the clinical picture. CRION should be thought of whenever presented with a steroid dependent optic neuritis with decreased ganglion cell layer thickness and negative anti-myelin oligodendrocyte glycoprotein antibodies.Downloads
References
Petzold A, Plant GT. Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol. 2013;261:17-26. doi:10.1007/s00415-013-6957-4
Lee HJ, Kim B, Waters P, Woodhall M, Irani S, Ahn S, et al. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies. J Neuroinflammation. 2018;15:302. doi:10.1186/s12974-018-1335-x
Kidd D, Burton B, Plant GT, Graham EM. Chronic relapsing inflammatory optic neuropathy (CRION). Brain. 2003;126:276-84. doi:10.1093/brain/awg045
Ambrosius W, Michalak S, Kozubski W, Kalinowska A. Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management. Int J Mol Sci. 2021;22:100. doi:10.3390/ijms22010100
Peschi P, Bradl M, Höftberger R, Berger T, Reindl M. Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases. Front Immunol. 2017;8:529. doi:10.3389/fimmu.2017.00529
Sechi E, Cacciaguerra L, Chen JJ, Flanagan EP. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management. Front Neurol. 2022;13:885218. doi:10.3389/fneur.2022.885218
Eslami M, Lichtman-Mikol S, Razmjou S, Bernitsas E. Optical coherence tomography in chronic relapsing inflammatory optic neuropathy, neuromyelitis optica and multiple sclerosis: a comparative study. Brain Sci. 2022;12:1140. doi:10.3390/brainsci12091140
Pascal S, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S, et al. Sarcoidosis: a clinical overview from symptoms to diagnosis. Cells. 2021;10:1-33. doi:10.3390/cells10040766
Ungprasert P, Carmona EM, Crowson CS, Matteson EL. Diagnostic utility of angiotensin converting enzyme in sarcoidosis: a population-based study. Lung. 2017;194:91-5. doi:10.1007/s00408-015-9826-3
Liu H, Zhou H, Wang J, Xu Q, Wei S. Antibodies to myelin oligodendrocyte glycoprotein in chronic relapsing inflammatory optic neuropathy. Br J Ophthalmol. 2019;103:1423-8. doi:10.1136/bjophthalmol-2018-313142
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Revista Sociedade Portuguesa de Oftalmologia

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Do not forget to download the Authorship responsibility statement/Authorization for Publication and Conflict of Interest.
The article can only be submitted with these two documents.
To obtain the Authorship responsibility statement/Authorization for Publication file, click here.
To obtain the Conflict of Interest file (ICMJE template), click here


